This platform aims to foster the development of new antitumour agents by studying their efficacy, toxicity and mechanism, but also targets the optimization of available agents. This lab offers these services to IBSAL research units, external research groups, hospital departments and companies.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site